Your browser doesn't support javascript.
loading
Benchmark datasets for SARS-CoV-2 surveillance bioinformatics.
Xiaoli, Lingzi; Hagey, Jill V; Park, Daniel J; Gulvik, Christopher A; Young, Erin L; Alikhan, Nabil-Fareed; Lawsin, Adrian; Hassell, Norman; Knipe, Kristen; Oakeson, Kelly F; Retchless, Adam C; Shakya, Migun; Lo, Chien-Chi; Chain, Patrick; Page, Andrew J; Metcalf, Benjamin J; Su, Michelle; Rowell, Jessica; Vidyaprakash, Eshaw; Paden, Clinton R; Huang, Andrew D; Roellig, Dawn; Patel, Ketan; Winglee, Kathryn; Weigand, Michael R; Katz, Lee S.
Afiliação
  • Xiaoli L; Strain Surveillance and Emerging Variant Team, Centers for Disease Control and Prevention, Atlanta, GA, United States of America.
  • Hagey JV; Strain Surveillance and Emerging Variant Team, Centers for Disease Control and Prevention, Atlanta, GA, United States of America.
  • Park DJ; Broad Institute of MIT and Harvard, Cambridge, MA, United States of America.
  • Gulvik CA; Strain Surveillance and Emerging Variant Team, Centers for Disease Control and Prevention, Atlanta, GA, United States of America.
  • Young EL; Utah Public Health Laboratory, Salt Lake City, UT, United States of America.
  • Alikhan NF; Quadram Institute Bioscience, Norwich Research Park, Norwich, United Kingdom.
  • Lawsin A; Strain Surveillance and Emerging Variant Team, Centers for Disease Control and Prevention, Atlanta, GA, United States of America.
  • Hassell N; Strain Surveillance and Emerging Variant Team, Centers for Disease Control and Prevention, Atlanta, GA, United States of America.
  • Knipe K; Strain Surveillance and Emerging Variant Team, Centers for Disease Control and Prevention, Atlanta, GA, United States of America.
  • Oakeson KF; Utah Public Health Laboratory, Salt Lake City, UT, United States of America.
  • Retchless AC; Strain Surveillance and Emerging Variant Team, Centers for Disease Control and Prevention, Atlanta, GA, United States of America.
  • Shakya M; Bioscience Division, Los Alamos National Laboratory, Los Alamos, NM, United States of America.
  • Lo CC; Bioscience Division, Los Alamos National Laboratory, Los Alamos, NM, United States of America.
  • Chain P; Bioscience Division, Los Alamos National Laboratory, Los Alamos, NM, United States of America.
  • Page AJ; Quadram Institute Bioscience, Norwich Research Park, Norwich, United Kingdom.
  • Metcalf BJ; Strain Surveillance and Emerging Variant Team, Centers for Disease Control and Prevention, Atlanta, GA, United States of America.
  • Su M; Strain Surveillance and Emerging Variant Team, Centers for Disease Control and Prevention, Atlanta, GA, United States of America.
  • Rowell J; SARS-CoV-2 Emerging Variant Sequencing Project Dry Lab Group Laboratory and Testing Task Force COVID-19 Emergency Response, Centers for Disease Control and Prevention, Atlanta, GA, United States of America.
  • Vidyaprakash E; SARS-CoV-2 Emerging Variant Sequencing Project Dry Lab Group Laboratory and Testing Task Force COVID-19 Emergency Response, Centers for Disease Control and Prevention, Atlanta, GA, United States of America.
  • Paden CR; Strain Surveillance and Emerging Variant Team, Centers for Disease Control and Prevention, Atlanta, GA, United States of America.
  • Huang AD; SARS-CoV-2 Emerging Variant Sequencing Project Dry Lab Group Laboratory and Testing Task Force COVID-19 Emergency Response, Centers for Disease Control and Prevention, Atlanta, GA, United States of America.
  • Roellig D; Strain Surveillance and Emerging Variant Team, Centers for Disease Control and Prevention, Atlanta, GA, United States of America.
  • Patel K; Strain Surveillance and Emerging Variant Team, Centers for Disease Control and Prevention, Atlanta, GA, United States of America.
  • Winglee K; Strain Surveillance and Emerging Variant Team, Centers for Disease Control and Prevention, Atlanta, GA, United States of America.
  • Weigand MR; Strain Surveillance and Emerging Variant Team, Centers for Disease Control and Prevention, Atlanta, GA, United States of America.
  • Katz LS; Strain Surveillance and Emerging Variant Team, Centers for Disease Control and Prevention, Atlanta, GA, United States of America.
PeerJ ; 10: e13821, 2022.
Article em En | MEDLINE | ID: mdl-36093336
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Tipo de estudo: Screening_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Tipo de estudo: Screening_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article